Plasma insulin in appropriate- and small-for-gestational-age fetuses

https://doi.org/10.1016/0002-9378(89)90167-1Get rights and content

Abstract

Plasma insulin and blood glucose levels were measured in umbilical venous samples obtained by cordocentesis from 42 small-for-gestational-age and 68 appropriate-for-gestational-age fetuses at 17 to 38 weeks' gestation. In the appropriate-for-gestational-age fetuses plasma insulin and the insulin/glucose ratio increased exponentially with gestation, reflecting the progressive maturation of the pancreas. Maternal blood glucose concentration, not fetal plasma insulin, was the major determinant of fetal blood glucose concentration. In some small-for-gestational-age fetuses hypoinsulinemia and hypoglycemia were found; the two were significantly correlated. However, the fetal insulin/glucose ratio was lower in small-for-gestational-age fetuses than in appropriate-for-gestational-age ones, suggesting that hypoinsulinemia in small-for-gestational-age fetuses is not only the result of hypoglycemia but also a consequence of pancreatic dysfunction. The degree of fetal smallness did not correlate with plasma insulin or with the insulin/glucose ratio. These findings suggest that insulin may influence fetal growth through its action on nutrient uptake and utilization but it is not the primary determinant of fetal size. (Ann J OBSTET GYNECOL. 1989;160:1091-4.)

References (15)

There are more references available in the full text version of this article.

Cited by (136)

  • Risk factors for hyperglycemia in extremely low birth weight infants during the first 14 days

    2022, Pediatrics and Neonatology
    Citation Excerpt :

    In this setting, the pancreas would need to produce insulin to compensate for the low insulin level. However, the pancreatic beta cells in an ELBWI are too immature for this function, leading to relative insulin deficiency.13,14 The present study suggests that hyperglycemia is related to probiotic type (B. breve M-16V).

  • Pathophysiology and Management of Disorders of Carbohydrate Metabolism and Neonatal Diabetes

    2020, Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management
  • Pathophysiology and Management of Disorders of Carbohydrate Metabolism and Neonatal Diabetes

    2019, Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management
  • Developmental Origins of Adult Health and Disease

    2016, Obstetrics: Normal and Problem Pregnancies
  • Maternal diabetes, programming of beta-cell disorders and intergenerational risk of type 2 diabetes

    2014, Diabetes and Metabolism
    Citation Excerpt :

    However, the susceptibility to T2D of low-birth-weight individuals has also been hypothesized as attributable to inadequate BCM formation [15]. The foetal period is critical for endocrine pancreatic development in rodents and in humans [19], and the clinical data show that children and adults with low birth weights have impaired beta-cell function compared with their normal-birth-weight counterparts [20,21]. Indeed, one report concluded that human foetuses with severe growth retardation have a reduction in pancreatic endocrine cell mass on autopsy [22].

View all citing articles on Scopus
View full text